Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis
- PMID: 12163784
- DOI: 10.1097/00003246-200208000-00009
Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis
Abstract
Objective: To determine the precise relationship among tissue factor, tissue factor pathway inhibitor (TFPI), and neutrophil elastase in sepsis, as well as to test the hypothesis that low TFPI concentrations are not sufficient to prevent tissue factor-dependent intravascular coagulation, leading to multiple organ dysfunction syndrome and death.
Design: Prospective, cohort study.
Setting: General intensive care unit of tertiary care emergency department.
Patients: Thirty-one consecutive patients with sepsis, classified as 15 survivors and 16 nonsurvivors. Ten normal, healthy volunteers served as controls.
Interventions: None.
Measurements and main results: Tissue factor antigen concentration (tissue factor), TFPI, neutrophil elastase, and global variables of coagulation and fibrinolysis were measured on the day of diagnosis of sepsis, severe sepsis, and septic shock and days on 1-4 after diagnosis. The number of systemic inflammatory response syndrome criteria that patients met and the disseminated intravascular coagulation score were determined simultaneously. The results of these measurements were compared between the survivors and the nonsurvivors. In the nonsurvivors, significantly higher concentrations of tissue factor and neutrophil elastase were found compared with the survivors and control subjects. However, the TFPI values showed no difference between the two groups. No correlation was found between the peak concentrations of tissue factor and TFPI. Disseminated intravascular coagulation scores and numbers of the SIRS criteria met by the survivors significantly decreased from day 0 to day 4, but those of the nonsurvivors did not improve during the study period. The nonsurvivors showed thrombocytopenia and higher numbers of dysfunctioning organs than did the survivors.
Conclusions: We systematically elucidated the relationship between tissue factor and TFPI in patients with sepsis, severe sepsis, and septic shock. Activation of tissue factor-dependent coagulation pathway not adequately balanced by TFPI has important roles in sustaining DIC and systemic inflammatory response syndrome, and it contributes to multiple organ dysfunction syndrome and death. High concentrations of neutrophil elastase released from activated neutrophils may explain, in part, the imbalance of tissue factor and TFPI in sepsis.
Comment in
-
The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis.Crit Care Med. 2002 Aug;30(8):1914-5. doi: 10.1097/00003246-200208000-00046. Crit Care Med. 2002. PMID: 12163821 No abstract available.
Similar articles
-
Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients.Crit Care Med. 2001 Feb;29(2):262-6. doi: 10.1097/00003246-200102000-00006. Crit Care Med. 2001. PMID: 11246303
-
Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients.Thromb Res. 2003 Jan 25;109(2-3):119-24. doi: 10.1016/s0049-3848(03)00151-8. Thromb Res. 2003. PMID: 12706640 Clinical Trial.
-
Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome.Crit Care Med. 1997 Nov;25(11):1820-6. doi: 10.1097/00003246-199711000-00019. Crit Care Med. 1997. PMID: 9366764
-
Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis.Crit Care Med. 2000 Sep;28(9 Suppl):S31-3. doi: 10.1097/00003246-200009001-00007. Crit Care Med. 2000. PMID: 11007194 Review.
-
Coagulation inhibitors in sepsis and disseminated intravascular coagulation.Intensive Care Med. 2000 Nov;26(11):1701-6. doi: 10.1007/s001340051349. Intensive Care Med. 2000. PMID: 11193281 Review.
Cited by
-
Markers of inflammation and coagulation may be modulated by enteral feeding strategy.JPEN J Parenter Enteral Nutr. 2012 Nov;36(6):732-40. doi: 10.1177/0148607111433054. Epub 2012 Feb 7. JPEN J Parenter Enteral Nutr. 2012. PMID: 22318965 Free PMC article. Clinical Trial.
-
COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response.Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620943293. doi: 10.1177/1076029620943293. Clin Appl Thromb Hemost. 2020. PMID: 32735131 Free PMC article. Review.
-
Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.J Huazhong Univ Sci Technolog Med Sci. 2009 Dec;29(6):697-700. doi: 10.1007/s11596-009-0604-4. Epub 2009 Dec 29. J Huazhong Univ Sci Technolog Med Sci. 2009. PMID: 20037809
-
Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shock.Crit Care. 2024 Oct 30;28(1):351. doi: 10.1186/s13054-024-05142-4. Crit Care. 2024. PMID: 39478586 Free PMC article.
-
Sepsis and disseminated intravascular coagulation.J Intensive Care. 2016 Mar 23;4:23. doi: 10.1186/s40560-016-0149-0. eCollection 2016. J Intensive Care. 2016. PMID: 27011792 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous